India to Ecuador: Carfilzomib Export Trade Route
India has recorded 2 verified shipments of Carfilzomib exported to Ecuador, representing a combined trade value of $53.3K USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $26.6K USD. The leading Indian exporter is REMUS PHARMACEUTICALS PRIVATE LIMITED, which accounts for 100% of total export value with 2 shipments worth $53.3K USD. On the buying side, ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the largest importer in Ecuador with $53.3K USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Ecuador Carfilzomib corridor is one of India's established pharmaceutical export routes, with 2 shipments documented worth a combined $53.3K USD. The route is dominated by REMUS PHARMACEUTICALS PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's carfilzomib manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $26.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 72% of all shipments, consistent with carfilzomib's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 11.8%, placing it at rank #19 among India's top carfilzomib export destinations globally.
On the import side, key buyers of Indian carfilzomib in Ecuador include ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA. ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the single largest importer with 2 shipments valued at $53.3K USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSAHAR AIR
Market Position
- Global rank#19
- Annual growth+11.8%
- Demand growth+10.6%
- Regulatory ease74/100
Top 10 Indian Carfilzomib Exporters to Ecuador
Showing top 10 of 1 Indian suppliers exporting Carfilzomib to Ecuador, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | REMUS PHARMACEUTICALS PRIVATE LIMITED Avg $26.6K per shipment | 2 | $53.3K | 100.0% |
This table shows the top 10 of 1 Indian companies exporting carfilzomib to Ecuador, ranked by total trade value. The listed exporters are: REMUS PHARMACEUTICALS PRIVATE LIMITED. REMUS PHARMACEUTICALS PRIVATE LIMITED is the dominant supplier with 2 shipments worth $53.3K USD, giving it a 100% market share.
Top 10 Carfilzomib Importers in Ecuador
Showing top 10 of 1 known buyers in Ecuador receiving Carfilzomib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian carfilzomib in Ecuador include ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA. The largest importer is ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA, accounting for $53.3K USD across 2 shipments — representing 100% of all carfilzomib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA | 2 | $53.3K | 100.0% |
Top 10 Carfilzomib Formulations Imported by Ecuador
Showing top 10 of 1 product formulations shipped on the India to Ecuador Carfilzomib route, ranked by trade value
Ecuador imports a wide range of carfilzomib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION: CARFILZOMIB FOR INJECTION 60MG/VIAL [PACK: 1 VIAL] — accounts for $53.3K USD across 2 shipments. A total of 1 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NON HAZARDOUS PHARMACEUTICAL FINISH PRODUCT FOR HUMAN CONSUMPTION: CARFILZOMIB FOR INJECTION 60MG/VIAL [PACK: 1 VIAL] | 2 | $53.3K | 100.0% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 72%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR handles the highest volume with 2 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's carfilzomib exports to Ecuador are driven primarily by a handful of large-scale manufacturers. REMUS PHARMACEUTICALS PRIVATE LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Ecuador benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — REMUS PHARMACEUTICALS PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $26.6K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
On the buying side, ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the largest importer with 2 shipments worth $53.3K USD — representing 100% of all carfilzomib imports from India on this route.
Route Statistics
- Trade Volume
- $53.3K
- Avg. Shipment
- $26.6K
- Suppliers
- 1
- Buyers
- 1
- Transit (Sea)
- ~21 days
- Annual Growth
- +11.8%
Related Analysis
Other Carfilzomib Routes
Unlock the Full India to Ecuador Carfilzomib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 2 shipments on this route.
Frequently Asked Questions — India to Ecuador Carfilzomib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Carfilzomib to Ecuador?
The leading Indian exporters of Carfilzomib to Ecuador are REMUS PHARMACEUTICALS PRIVATE LIMITED. REMUS PHARMACEUTICALS PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Carfilzomib exports from India to Ecuador?
India exports Carfilzomib to Ecuador worth approximately $53.3K USD across 2 recorded shipments. The average value per shipment is $26.6K USD.
Q Which ports does India use to ship Carfilzomib to Ecuador?
The most active port of origin is SAHAR AIR with 2 shipments. Indian exporters primarily use sea freight for this route, with 72% of shipments going by sea and 20% by air.
Q How long does shipping take from India to Ecuador for Carfilzomib?
The average transit time for Carfilzomib shipments from India to Ecuador is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to Ecuador Carfilzomib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 11.8% with demand growth tracking at 10.6%. The route is ranked #19 among India's top Carfilzomib export destinations globally.
Q How many suppliers are active on the India to Ecuador Carfilzomib route?
There are currently 1 active Indian suppliers exporting Carfilzomib to Ecuador. The market is moderately concentrated with REMUS PHARMACEUTICALS PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Carfilzomib from India in Ecuador?
The leading importers of Indian Carfilzomib in Ecuador include ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA. ZETI PHARMACEUTICALS PHARMAZETI CIALIMITEDA is the largest buyer with 2 shipments worth $53.3K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Ecuador export trade corridor identified from Indian Customs (DGFT) records for Carfilzomib.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 1 importers in Ecuador matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 2 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
2 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists